通过下一代测序对新型HLA-DPB1*1763:01等位基因进行表征
Jie Liu1, Zhan-Rou Quan1, Bing-Na Yang1
1Shenzhen Institute of Transfusion Medicine, Shenzhen Blood Center, Shenzhen, Guangdong, China.
HLA
|July 31, 2025
概括
一种新的人类白细胞抗原 (HLA) 变体,HLA-DPB1*1763:01已被确定. 这种变异与HLA-DPB1*02:01:64的区别在于,在第1个外构体中的14号码子中单个核酸替代.
科学领域:
- 免疫遗传学 免疫遗传学
- 分子生物学分子生物学
背景情况:
- 人类白细胞抗原 (HLA) 系统在免疫反应中起着至关重要的作用.
- 在HLA基因内的遗传变异有助于不同的免疫特征和疾病易感性.
研究的目的:
- 为了表征一种新发现的HLA-DPB1等位基因.
- 详细介绍小说和已知的HLA-DPB1等位基因之间的特定遗传差异.
主要方法:
- 对HLA-DPB1基因进行序列分析.
- 不同HLA-DPB1等位基因之间的核酸序列的比较.
主要成果:
- 一个新的HLA-DPB1等位基因被确定,被指定为HLA-DPB1*1763:01.
- 这种新等位基因通过单个核酸替代与HLA-DPB1*02:01:64不同.
- 这种替代发生在HLA-DPB1基因的第1个异构体内的14号码子.
结论:
- 鉴定HLA-DPB1*1763:01扩大了已知的HLA等位基因库.
- 了解这些特定的遗传变异对于高分辨率的HLA类型和免疫学研究至关重要.
相关概念视频
Next-generation Sequencing
88.0K
The first human genome sequencing project cost $2.7 billion and was declared complete in 2003, after 15 years of international cooperation and collaboration between several research teams and funding agencies. Today, with the advent of next-generation sequencing technologies, the cost and time of sequencing a human genome have dropped over 100 fold.
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features....
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features....
88.0K
Single Nucleotide Polymorphisms-SNPs
14.8K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
14.8K
Genome-wide Association Studies-GWAS
12.7K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
12.7K


